Analyst Report: AKAM
1. EXECUTIVE SUMMARY
Akamai closed Monday 26 October at $98.50, up 5.31% from $93.53, and the research brief identifies no company-specific catalyst for that session. The stock had already climbed 12.89% from $87.25 on 19 October, helped by a rebound in cloud and edge-delivery stocks that Trefis described on Friday 23 October. The shares remain 9.62% below their level 20 sessions ago, after a September rally on the Anthropic contract faded and two October target cuts from Piper Sandler and UBS. Monday's gain, on volume of 1.22x the 50-session average, looks like a continuation of the sector rebound (inference). The next test is third-quarter earnings on 5 November.
2. THE CATALYST
The brief could not establish a cause for Monday's move. The only candidate was an auto-generated MarketWatch headline from that evening, which the research assistant could not open, so it is not used as evidence.
The nearest documented driver sits in the prior session. Trefis reported on 23 October that edge delivery companies were setting the pace in a broadening rebound in cloud software stocks, with Zscaler up 7.3% and Fastly up 8.7% and Akamai also higher. Akamai gained 2.63% that day to close at $93.53. Because that explains Friday and not Monday, the Monday move has no confirmed reason.
| Session | Close | Change | Volume |
|---|---|---|---|
| 2026-10-22 | $91.13 | +0.95% | 5,122,800 |
| 2026-10-23 | $93.53 | +2.63% | 4,010,600 |
| 2026-10-26 | $98.50 | +5.31% | 5,766,200 |
On Monday the S&P 500 rose 0.70%, VeriSign rose 2.80% and GoDaddy fell 2.63%. The peers gave mixed support, so market direction accounts for only a small part of Akamai's gain.
3. COMPANY PROFILE
Akamai Technologies provides security, content delivery and cloud computing services. Its security products cover web application and API protection, bot and abuse defence, and account takeover and credential stuffing protection. It sits in the Software - Infrastructure industry, and the facts panel groups it with VeriSign and GoDaddy among internet infrastructure peers. The brief also names Zscaler and Fastly as sector comparisons for the edge-delivery rebound.
The most important recent development is the Anthropic agreement announced on 24 September. According to Indmoney, Anthropic committed $11.6 billion over seven years for cloud infrastructure supporting CPU workloads. Indmoney and Simply Wall St report that the commitment can expand by up to $9 billion and that Akamai expects about $5.5 billion of capex tied to the initial portion. Tikr reports that service starts in late Q2 2027, with full run-rate expected by the end of 2028. An Akamai 8-K exhibit shows a warrant issued to Anthropic for 7.7 million shares, about 5% of common stock outstanding, at an exercise price of $111.33. Indmoney reports that 2026 revenue guidance was unchanged by the deal.
Consensus for the third quarter stands at EPS of $1.67 and revenue of $1.12bn.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The brief offers no new fundamental information for 26 October. The gain therefore reads as a trading rebound (inference) after a steep drawdown. The shares fell 8.23% on 14 October and 4.89% on 16 October, on volume of 7,980,800 and 7,422,700, and the brief does not explain either drop. Since the 19 October close of $87.25 the stock has recovered most of those losses.
Analyst stance. Piper Sandler's James Fish kept Overweight and cut the target from $158 to $120 on 21 October, a 24% reduction (GuruFocus; MarketBeat). UBS cut its target from $148 to $100 and kept Neutral on 22 October (Stock Observer). DA Davidson cut its target from $185 to $150 with a Buy rating on 28 September. MarketBeat lists consensus as "Moderate Buy" with a mean target of $146. A Raymond James upgrade to strong-buy with a $170 target appears in the feed, but its date is unclear and it is unconfirmed. UBS's $100 target sits only 1.5% above Monday's close.
Comparable episodes. After the Anthropic announcement, Reuters reported a rise of roughly 22% in extended trading, TheStreet reported an intraday jump of as much as 16.4% on 25 September with a close near $115, and Futuriom noted shares near $110.70 by 28 September. The shares have since fallen well below that level. A MarketWatch headline also shows a 12.33% session on 15 September, with the cause unverified.
Bull case. Morgan Stanley raised its revenue growth estimate to about 16% from 12.5%, on $150m to $300m of expected added revenue in 2027 (Yahoo Finance, 25 September). The forward P/E of 14.4 compares with a trailing P/E of 35.7, which implies sharp expected earnings growth. The shares are up 15.75% year to date.
Bear case. The $5.5 billion capex commitment and the warrant at $111.33 add dilution and spending risk. The stock sits 40.5% below its 52-week high of $165.45. Two target cuts in the week before Monday show analysts trimming expectations.
5. TECHNICAL SNAPSHOT
At $98.50 the stock trades below its 50-day average of $105.40 and its 200-day average of $112.41, so the longer trend remains down despite the bounce. The price sits between the 52-week low of $70.82 and the high of $165.45, nearer the lower end of that range. Monday's volume of 5,766,200 ran at 1.22x the 50-session average, which is firmer than the 4,010,600 on Friday but well below the 8,402,800 recorded on 15 October. The nearest support is the prior close of $93.53, and the nearest resistance is the 13 October close of $99.93, followed by the 50-day average at $105.40.
6. RISK FACTORS
- Monday's gain has no confirmed cause, so it may reverse as readily as it formed.
- The sector rebound that lifted the shares depends on continued strength in cloud software names.
- Third-quarter results on 5 November test the consensus of $1.67 EPS and $1.12bn revenue. Ad-hoc News labelled a $1.10bn figure as second-quarter results, which may be an error, so the revenue baseline carries some uncertainty.
- Capex of about $5.5 billion for the Anthropic build-out starts before service begins in late Q2 2027.
- Further target cuts would follow the Piper Sandler and UBS moves.
Dated catalyst: Q3 2026 earnings on 5 November 2026.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). The shares have risen four sessions in a row into earnings. Resistance at $99.93 and then $105.40 caps the near-term path, and a fall below $93.53 would erase Friday and Monday's gains. The 5 November report will drive the move.
Medium term (1-3 months). The direction depends on whether management gives detail on Anthropic capex, margins and 2027 revenue, which Morgan Stanley puts at $150m to $300m of added revenue. A reclaim of the 50-day average at $105.40 would show the post-deal decline has ended. Analyst targets of $100 to $120 from UBS and Piper Sandler frame the nearer valuation range.
Long term. The thesis rests on the Anthropic contract and the growth it adds from 2027, and nothing in the brief changes that. The contract terms, including the warrant strike of $111.33, remain the reference points. This is analysis only and not personal financial advice.